HIV-associated lipodystrophy syndrome: assessment and management.
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Journal of Infection
- Vol. 46 (2) , 87-93
- https://doi.org/10.1053/jinf.2002.1103
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Use of Human Immunodeficiency Virus-1 Protease Inhibitors Is Associated With Atherogenic Lipoprotein Changes and Endothelial DysfunctionCirculation, 2001
- Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitorsAIDS, 2000
- P39 Measuring insulin sensitivity in HIV-infected patients using the hyperinsulinaemic euglycaemic clamp techniqueHIV Medicine, 2000
- Myocardial Infarction in HIV-Infected Men Receiving Protease InhibitorsAnnals of Internal Medicine, 1999
- Avascular necrosis in HIV infectionAIDS, 1999
- Acute pancreatitis in human immunodeficiency virus–infected patients: a reviewThe American Journal of Medicine, 1999
- Osteonecrosis of the femoral head in patients receiving HIV protease inhibitorsAIDS, 1999
- Vascular complications associated with use of HIV protease inhibitorsThe Lancet, 1998
- Severe premature coronary artery disease with protease inhibitorsThe Lancet, 1998
- Association of Coronary Heart Disease Incidence with Carotid Arterial Wall Thickness and Major Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993American Journal of Epidemiology, 1997